Supplementary figure 1
description
Transcript of Supplementary figure 1
Supplementary figure 1S
urfa
ce m
arke
r exp
ress
ion
in %
0 13 17 280
20
40
60
80
100
120
CD31CD34VEGFR2
days
A
B
Supplementary figure 1: Characterization of dmECFC and hECFC. ECFC clones showed a typical morphology. From left to right: 10x healthy, 10x dmECFCECFC, 40x magnification dmECFC (A). Expression of endothelial and progenitor markers in dmECFC and hECFC (n=3, B). Expression of CD31, CD34, and VEGFR2 was determined by flow cytometry over time (n=4-6/time point; C).
CD31 CD34 VEGFR20
20
40
60
80
100
120
hECFCdmECFC
C
Sur
face
mar
ker e
xpre
ssio
n in
%
hECFC dmECFC
HP
RT
Adi
poR
1
Adi
poR
2
yECFC dmECFC
HP
RT
Adi
poR
1
Adi
poR
2
Supplementary figure 2
A
B
AdipoR1 AdipoR20
20
40
60
80
100
120
Rel
ativ
e ad
ipon
ectin
rece
ptor
exp
ress
ion
in d
mE
CFC
(in
% h
EC
FC)
Supplementary figure 2: mRNA expression of the specific adiponectin receptors AdipoR1 and AdipoR2 in diabetic and non-diabetic ECFC. RT-PCR for yECFC and dmECFC using hypoxanthine-guanine phosphoribosyl transferase (HPRT) as loading control (A), real-time PCR for age-matched hECFC and dmECFC using 18 S rRNA as house keeping gene (B).
*N
itrite
con
cent
ratio
n in
% c
ontro
l
control gArcp0
20
40
60
80
100
120
140
160
Supplementary figure 3: Concentration of nitrite as a quantitative measure of nitric oxide production in cell culture supernatants, *: p<0.05 vs. control, n=3.
Supplementary figure 3